Patholytix
Patholytix Is Your Single Solution For Research And Translational Pathology
Patholytix delivers a scalable, GLP compliant, digital pathology management solution including Viewer, Image QC, Storage, AI Decision support and WSI synced data capture.
Patholytix Preclinical is a fully scalable solution that grows in line with your organisational needs. Add users, expand capabilities, and add on modules to fit your use cases as you need them.
SUPERIOR ERGONOMICS IN STUDY MANAGEMENT
Patholytix is designed for physical comfort whilst you work. You are no longer hunched over a microscope. You suffer less neck and wrist strain.
Sort and review slides at the click of a button, versus 2-3 hours of tedious sorting and prep of glass slides.
Simplify your work in every single way, with no loss of detail compared to the microscope.
REVOLUTIONARY CLOUD-BASED INFRASTRUCTURE
Revolutionary cloud-based infrastructure allows on-demand collaboration between remote Pharma, CRO partners and specialist Consultants from any location around the world.
Studies can be reviewed concurrently by different pathologists, speeding up study outcomes. When combined this leads to easier and faster collaboration with partners in your network.


“Patholytix is the first viewer that adopts a study-centric approach from the ground up; combined with its excellent metadata management it makes primary evaluation, peer review and blind assessment of nonclinical toxicology studies very efficient, and in some ways even more efficient than the microscope.”

PATHOLOGY’S MOST FLEXIBLE STUDY TEMPLATES
Flexible study templates allow you to define your study by the parameters important to you. This data forms the information by which the study is filtered in the Study Browser. This allows you to intelligently interact with your study the way you want to – a feature not possible with any existing study management system.
ISO27001 CERTIFICATION
ISO27001 certification confirms that our entire range of services offer the confidence and security to enable the management of WSI, study metadata, and distribution of slides to partners.
Through rigorous ISO 27001 process and technical controls, your data remains secure at every point in our ecosystem – from the moment you upload a study to the point a remote partner completes their review.


HYBRID SOLUTION FOR SECURITY & PERFORMANCE
Studies are delivered to you securely ensuring data integrity, continuity and most importantly, high performance. This allows for seamless review and transition between images and resolutions.
Image viewing is identical in detail to your microscope. At the touch of a button or twist on the ergonomic mouse, you can go between magnifications very quickly and move on to the next slide.
Offering a blend of workflow design, viewing performance, and ease of use that delivers a truly unique digital pathology experience.
| Deployment Model | Cloud, Hybrid |
|---|---|
| Primary Target Use | AI integration, Case Sharing, Collaborative Annotation, Data Management, Data Sharing, Drug Development, Preclinical Research, Remote Consultations, Remote Diagnosis, Research, Toxicologic Pathology |
| Supported Image Formats | BIF, CZI, iSyntax, MRXS, NDPI, OME.TIFF, SCN, SVS, TIFF, VSI |
| Zero-Footprint Viewer | Yes |
| Remote Applications | Case Sharing, Collaborative Annotation, Remote Consultations, Remote Diagnosis |
| Security Features | ISO 27001 Certified |
More Solutions from Deciphex,Diagnexia
Compare Solutions
Get Pathology News Delivered to Your Inbox
Learn More
Deciphex,Diagnexia News
Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
Editor2025-10-13T09:30:21+00:00October 2, 2025|
Deciphex Reinforces Growth Trajectory in Global Pathology with Appointment of Industry Leader Greg Wigmore as CFO
admin@pathologynews.com2025-05-06T13:00:17+00:00May 6, 2025|
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
admin@pathologynews.com2025-02-11T12:13:36+00:00February 11, 2025|
Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development
admin@pathologynews.com2025-01-28T09:36:24+00:00January 28, 2025|
Deciphex Secures $32.3M Series C to Address Global Pathology Shortage
admin@pathologynews.com2025-01-08T09:36:40+00:00January 8, 2025|
Deciphex: 2023 Company of the Year Speaks at the Irish Medtech Awards
admin@pathologynews.com2024-12-19T13:53:43+00:00December 19, 2024|
Novartis Ireland and Deciphex: Pioneering AI Collaboration to Advance Healthcare Innovation
admin@pathologynews.com2024-11-26T09:30:28+00:00November 26, 2024|













Reviews
There are no reviews yet.